Uncertain Times: Korean Pharma Braces For Trump, Political Turmoil

Mixed Signals For Industry

 
• By Jung Won Shin

At a new year’s briefing, KPBMA's president talked about what may be ahead for Korean biopharma firms in a challenging and uncertain environment amid the start of the second Trump Administration and ongoing political turmoil in Korea.

Yunhong Noh, KPBMA President
“Each And Every One Has To Faithfully Carry Out Their Work Even At Times Of Uncertainties” (KPBMA)

More from South Korea

More from Business